22nd Century Group, Inc. (15)
Browse by Contract Category
Contracts
-
Employment Agreement between the Company and John Franzino
(Filed With SEC on June 3, 2020)
-
Description of Securities Registered Pursuant to Section 12
(Filed With SEC on March 11, 2020)
-
Convertible Note of Panacea Life Sciences., Inc., dated December 3, 2019, issued to 22nd Century Group, Inc
(Filed With SEC on December 3, 2019)
-
Employment Agreement between the Company and James Mish
(Filed With SEC on June 3, 2020)
-
Employment Agreement between the Company and Andrea S. Jentsch
(Filed With SEC on January 3, 2020)
-
Series B Preferred Stock Purchase Agreement, dated as of December 3, 2019, between Panacea Life Sciences., Inc and 22nd Century Group, Inc
(Filed With SEC on December 3, 2019)
-
Warrant to purchase shares of Series B Preferred Stock of Panacea Life Sciences., Inc., dated December 3, 2019, issued to 22nd Century Group, Inc
(Filed With SEC on December 3, 2019)
-
Side Agreement, dated as of December 3, 2019, Panacea Life Sciences, Inc., [EMPLOYEE], [EMPLOYEE], [EMPLOYEE], [EMPLOYEE], Quintel-MC Incorporated, and 22nd Century Group, Inc
(Filed With SEC on December 3, 2019)
-
Form of Warrant Exercise Agreement
(Filed With SEC on November 25, 2019)
-
Form of New Warrant Agreement
(Filed With SEC on November 25, 2019)
-
Employment Agreement between the Company and Clifford B. Fleet
(Filed With SEC on September 13, 2019)
-
Employment Agreement between the Company and Michael J. Zercher
(Filed With SEC on September 13, 2019)
-
Framework Collaborative Research Agreement, dated as of April 3, 2019, between KeyGene N.V. and 22nd Century Group, Inc
(Filed With SEC on May 7, 2019)
-
Form of Executive Restricted Stock Unit Award Agreement under 22nd Century Group, Inc. 2014 Omnibus Incentive Plan, as amended and restated
(Filed With SEC on March 6, 2019)
-
Form of Director Restricted Stock Unit Award Agreement under 22nd Century Group, Inc. 2014 Omnibus Incentive Plan, as amended and restated
(Filed With SEC on March 6, 2019)